Act, unite and empower
Accessed: 29.06.2019
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
QualityRights is WHO’s global initiative to improve the quality of care provided by mental health services and promote the human rights of people with psychosocial, intellectual and cognitive disabilities1. It offers a new approach to mental health care which is rights-based and recovery-oriented.
Q7: For people with dementia, who should be told of the diagnosis and how should the diagnosis be delivered?
Health Benefits and Associated Risks
Accessed: 02.03.2020
Rwanda Guidelines for variation to registered pharmaceutical products.
As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including more than 285,000 deaths have been reported to WHO. The risk of severe disease and death has been highest in older people and in persons with underlying noncommunicable diseases (NCDs), such as hypertension, cardiac diseas...e, chronic lung disease and cancer.
more
This fact sheet explains how you can help prevent the spread of COVID-19 - in 35 languages
Country statistics and global health estimates by WHO and UN partners | For more information visit the Global Health Observatory (http://www.who.int/gho/en/)